our products

我们的产品

 

 

 

 

 

编号

No

 

项目名称

Project name

 

适应症以

Indications

工作进程

Work process

详细

Details

01 盐酸利多卡因眼用凝胶

Lidocaine Hydrochloride Eye Gel

 

眼科手术,局麻

Eye surgery, local anesthesia

3.5%(5ml:0.175g;1ml:0.035g)

 

 

在研

At the research institute

 

详细

Details

02 卡波姆眼用凝胶

Carbomer Eye Gel

 

干眼症

Dry eye

10g:20mg(0.2%)

 

在研

At the research institute

详细

Details

03  

复方氯替泼诺妥布霉素滴眼液

Compound Loteprednol Tobramycin Eye Drops

 

 

眼部炎症

Eye inflammation

  5ml:氯替泼诺25mg与妥布霉素15mg

 

 

技术成熟

Mature technology

 

详细

Details

04 氯替泼诺原料药及混悬滴眼液

Loteprednol bulk drug and suspension eye drops

 

1.眼睑和球结膜炎症

2.眼部手术后的术后炎症

1. Inflammation of the eyelids and bulbar conjunctiva
2. Postoperative inflammation after eye surgery

规格:0.2%;0.5%

 

技术成熟

Mature technology

详细

Details

05  

他克莫司滴眼液研

Tacrolimus Eye Drops Research

 

 0.1% 在研

At the research institute

详细

Details

06 环孢素眼用乳液(胶束)
Cyclosporine ophthalmic emulsion (micelle)
 

干眼症

Dry eye

规格:0.09%

 

在研

At the research institute

详细

Details

07  

贝美前列素

Bimatoprost   Ophthalmic Solution 

 

开角型青光眼、高眼压症

Open angle glaucoma, ocular hypertension

已申报

Declared

详细

Details

08  

曲伏前列素

Travoprost Eye Drops 

 

开角型青光眼、高眼压症

Open angle glaucoma, ocular hypertension

即将批准生产

Approved for production soon

详细

Details

09 二氟泼尼酯眼用乳剂

Difluprednate Eye drops

 

眼科术后出现的炎症和疼痛

Inflammation and pain after ophthalmology surgery

 

 

原料工艺确定,分析方法,质量标准已确定,制剂工艺确定

The material technology is determined, the analysis method, the quality standard has been determined, and the preparation technology is determined

 

详细

Details

10 地夸磷索钠滴眼液

Diquafosol Sodium Eye Drop s

 

治疗干眼症

Treatment of dry eye

 

 

原料工艺确定,分析方法,质量标准已确定,制剂工艺确定

The material technology is determined, the analysis method, the quality standard has been determined, and the preparation technology is determined

 

详细

Details

11 奈帕芬胺滴眼液

Pranoprofen Eye Drops

 

白内障术后疼痛和炎症

Pain and inflammation after cataract surgery

 

原料工艺确定

Raw material process determination

详细

Details

12  

Omidria复方眼用洗液

Omidria Compound eye lotion

 

 

内障和晶状体置换手术中的

扩瞳药物,以防止手术

中瞳孔缩小及缓解术后疼痛。

In cataract and lens replacement surgery
Pupil dilation drugs to prevent surgery
Middle pupils diminish and relieve postoperative pain.

 

 

原料来源确定,制剂处方工艺确定

The source of raw materials is determined, and the formulation process is determined.

详细

Details

13  

(酮咯酸氨丁三醇-盐酸去氧肾上腺素)

Omidria Compound Eye Lotion 

 

  技术成熟

Mature technology

 

详细

Details

14  

普拉洛芬滴眼液

Pranoprofen Eye Drops

 

 

外眼及眼前节炎症的对症治疗

Symptomatic treatment of inflammation of the outer eye and anterior segment

 

工艺确定,杂质具备

The process is confirmed, and the impurities are available

详细

Details

15 瑞巴派特混悬滴眼液

Rebate   Pitt Drops

 

干眼症

Dry eye

 

 

负责进口注册申报,已批临床

Responsible for import registration declaration, clinical approved

 

详细

Details

16 莫西沙星滴眼液

Moxifloxacin Hydrochloride Eye Drops 

 

抗生素

Antibiotics

 

工艺研究完成

Process research is completed.

详细

Details

17  

复方托吡卡胺滴眼液(单剂量)

Tropicamide Phenylephrine Eye Drops(Single dose)

 

 

诊断及治疗为目的的

散瞳和调节麻痹

For the purpose of diagnosis and treatment
Mydriasis and accommodative paralysis

 

实验室研究完成

Laboratory research completed

详细

Details

18 他氟前列素原料药及滴眼液

Tafluprost Eye Drops and API

 

降低开角型青光眼

或眼高压患者的眼内压

Reduce open angle glaucoma
Or intraocular pressure in patients with ocular hypertension

 

技术成熟

Mature technology

 

详细

Details

19  

阿卡他定滴眼液

LASTACAFT EYE DROPS

 

 

用于预防与过敏性

结膜炎相关的瘙痒

For prevention and allergy
Itching associated with conjunctivitis

 

 

技术成熟

Mature technology

 

详细

Details

20 立他司特原料药及滴眼液

Lifitegrast EYE DROPS and API

 

治疗有体征和

症状的干眼症

Treatment has signs and
Symptoms of dry eye

 

技术成熟

Mature technology

 

详细

Details

21  

阿托品滴眼液

Atropin EYE DROPS

 

   

 

详细

Details

 

22  

 

 

环孢素眼用乳剂 

Cyclosporine   ophthalmic emulsion

 


 
 

干眼症

Dry eye

规格为0.05%

 

 

1)目前,该制剂工艺开发并优化完成,单剂量规格(0.05%/0.4ml)已经过GMP车间10万支/批放量生产,工艺稳定,产品质量与原研一致,且稳定性等与原研一致。

1) At present, the preparation process has been developed and optimized. The single-dose specification (0.05%/0.4ml) has been produced in a GMP workshop of 100,000 pieces/batch. The process is stable, the product quality is consistent with the original research, and the stability is consistent with the original research. .

 

2)0.05%/3ml工艺、质量研究难度大,现已确定。

The process and quality of 0.05%/3ml are difficult to study, and it has been determined.

 

3)具备批文的合法原料药,且杂质制备获取完备

Legal APIs with approved documents and complete preparation of impurities.

 

4)分析方法,质量标准建立完善,单剂量申报资料已提交申报,多剂量正在完成。

Analytical methods, quality standards have been established and perfect, single-dose application materials have been submitted, and multiple-dose applications are being completed

 

5)已获临床批件。技术成熟

Has been clinically approved. Mature technology

 

详细

Details

--  

 

--

 

 

-- -- --